Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Norris Medicines Ltd. focuses on the development and production of pharmaceutical compounds, medicinal chemicals, and botanical extracts. Their diverse product range addresses various health concerns, encompassing categories like antibiotics, anti-inflammatory agents, anti-emetics, nutritional supplements, cough and cold remedies, dermatological and allergy treatments, anti-malarial drugs, and medications for diabetic and cardiac conditions. The company, which established its operations in 1990, is based in Ankleshwar, India.
Company Valuation
Based on key historical and expected multiples, the stock is greatly overvalued relative to its peers. Specifically, the stock is overvalued on EV/EBITDA.